Jump to:
Medcaw Investments PLC Fundamentals
| Company Name | Medcaw Investments PLC | Last Updated | 2025-06-03 |
|---|
| Industry | Asset Management | Sector | Financial Services |
|---|
| Shares in Issue | 22.132 m | Market Cap | £697,160.99 |
|---|
| PE Ratio | 0.00 | Dividend per Share | 0 |
|---|
| Dividend Yield | 0 | Dividend Cover | 0 |
|---|
| EPS | -£0.02 | EPS Growth (%) | 0 |
|---|
| PEG | 0 | DPS Growth (%) | 0 |
|---|
| Debt Ratio | 0 | Debt Equity Ratio | 0 |
|---|
| Asset Equity Ratio | -0.6030 | Cash Equity Ratio | -0.4426 |
|---|
| Quick Ratio | 0.2761 | Current Ratio | 0.38 |
|---|
| Price To Book Value | 0 | ROCE | 0 |
|---|
Medcaw Investments PLC Dividends
| Type | Ex-Date | Pay Date | Currency | Net Dividend | Year Total |
|---|
Medcaw Investments PLC Company Financials
| Assets | 2024 | 2023 | 2022 |
|---|
| Tangible Assets | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 |
| Total Fixed Assets | 0 | 0 | 0 |
| Stocks | 0 | 0 | 0 |
| Debtors | 0 | 0 | £187,160.00 |
| Cash & Equivalents | £72,286.00 | £371,484.00 | £643,872.00 |
| Other Assets | 0 | 0 | 0 |
| Total Assets | £98,477.00 | £511,807.00 | £831,032.00 |
| Liabilities | 2024 | 2023 | 2022 |
|---|
| Creditors within 1 year | £261,781.00 | £242,751.00 | £240,709.00 |
| Creditors after 1 year | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 |
| Total Liabilities | £261,781.00 | £242,751.00 | £240,709.00 |
| Net assets | -£163,304.00 | £269,056.00 | £590,323.00 |
| Equity | 2024 | 2023 | 2022 |
|---|
| Called up share capital | £221,320.00 | £221,320.00 | £171,320.00 |
| Share Premium | £1.01 m | £1.01 m | £679,110.00 |
| Profit / Loss | -£432,360.00 | -£712,170.00 | -£194,006.00 |
| Other Equity | -£163,304.00 | £269,056.00 | £590,323.00 |
| Preference & Minorities | 0 | 0 | 0 |
| Total Capital Employed | -£163,304.00 | £269,056.00 | £590,323.00 |
| Ratios | 2024 | 2023 | 2022 |
|---|
| Debt Ratio | 0 | 0 | 0 |
| Debt-to-Equity | 0 | 0 | 0 |
| Assets / Equity | -0.6030 | -0.6030 | -0.6030 |
| Cash / Equity | -0.4426 | -0.4426 | -0.4426 |
| EPS | -£0.01 | -£0.04 | -£0.02 |
| Cash Flow | 2024 | 2023 | 2022 |
|---|
| Cash from operating activities | -£133,935.00 | -£686,439.00 | -£31,909.00 |
| Cashflow before financing | -£133,935.00 | -£123,279.00 | £443,373.00 |
| Increase in Cash | -£299,198.00 | -£272,388.00 | £443,373.00 |
| Income | 2024 | 2023 | 2022 |
|---|
| Turnover | 0 | 0 | 0 |
| Cost of sales | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 |
| Operating Profit | -£463,238.00 | -£720,019.00 | -£194,006.00 |
| Pre-Tax profit | -£432,360.00 | -£712,170.00 | -£194,006.00 |
Medcaw Investments PLC Company Background
| Sector | Financial Services |
|---|
| Activities | Medcaw Investments PLC is an investment holding company. Its objective is to identify and acquire prospective lithium mining projects across Africa. It is developing the Kenticha lithium project located in the Oromia State, Southern Ethiopia. |
|---|
| Latest Interim Date | 27 Sep 2024 |
|---|
| Latest Fiscal Year End Date | 30 Apr 2025 |
|---|
Medcaw Investments PLC Directors
| Appointed | Name | Position |
|---|
| 2025-05-01 | Mr. Marcus Yeoman | Non-Executive Director,Chairman |
| 2025-05-01 | Mr. Charles Ainslie Wood | Executive Director |
| 2023-03-06 | Mr. Daniel John Shilton Maling | Non-Executive Director |
| 2025-05-01 | Ms. Sarah Cope | Non-Executive Director |
Medcaw Investments PLC Contact Details
Medcaw Investments PLC Advisors
